The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia | Zendy

Pérez Rodríguez | Zendy; Adrián Sousa | Zendy; Antonio MorenoFlores | Zendy; Rebeca Longueira | Zendy; Patricia Diéguez | Zendy; Milagros Suárez | Zendy; Olalla Lima | Zendy; Francisco J. Vasallo | Zendy; Maximiliano Álvarez-Fernández | Zendy; Manuel Crespo | Zendy

Open Access

The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia

Author(s) -

Pérez Rodríguez,

Adrián Sousa,

Antonio MorenoFlores,

Rebeca Longueira,

Patricia Diéguez,

Milagros Suárez,

Olalla Lima,

Francisco J. Vasallo,

Maximiliano Álvarez-Fernández,

Manuel Crespo

Publication year - 2020

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2020.10.097

Subject(s) - bacteremia , staphylococcus aureus , medicine , antibiotic therapy , antibiotics , intensive care medicine , microbiology and biotechnology , biology , bacteria , genetics

Treatment optimization for serious infections, such as Staphylococcus aureus bacteremia (SAB), is a challenge for antimicrobial stewardship teams. Currently, SAB guidelines recommend a completely intravenous therapy (CIT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog